Viewing Study NCT02068456


Ignite Creation Date: 2025-12-24 @ 11:25 PM
Ignite Modification Date: 2026-02-26 @ 12:41 AM
Study NCT ID: NCT02068456
Status: COMPLETED
Last Update Posted: 2017-06-22
First Post: 2014-02-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Post Marketing Surveillance of Roflumilast in Korea
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Obstructive Pulmonary Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Drug therapy View